Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.67% | 14.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.67% | 14.00% | |||
| Cost of Revenue | -43.87% | 160.36% | |||
| Gross Profit | 36.56% | -20.32% | |||
| SG&A Expenses | -0.52% | 5.28% | |||
| Depreciation & Amortization | 20.58% | -21.51% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.91% | 35.15% | |||
| Operating Income | 640.72% | -82.14% | |||
| Income Before Tax | 166.12% | -975.46% | |||
| Income Tax Expenses | 88.11% | -14,513.95% | |||
| Earnings from Continuing Operations | -21.53% | 1,081.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.53% | 1,081.63% | |||
| EBIT | 640.72% | -82.14% | |||
| EBITDA | 157.09% | -55.97% | |||
| EPS Basic | -21.15% | 1,060.71% | |||
| Normalized Basic EPS | 201.23% | -202.97% | |||
| EPS Diluted | -23.08% | 1,200.00% | |||
| Normalized Diluted EPS | 198.97% | -204.97% | |||
| Average Basic Shares Outstanding | -0.43% | 2.19% | |||
| Average Diluted Shares Outstanding | 1.86% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||